Thursday 28th of June
8:30 CELL, GENE AND TISSUE ENGINEERING-BASED TECHNOLOGIES AND PLATFORMS
Chair: Shomi Bhattacharya. CABIMER. SPAIN
8:35 Advanced Delivery Systems for Cell Therapies
Robert Brown University College of London. UNITED KINGDOM.
8:55 How many cells are needed for Tissue Engineering?
C. James Kirkpatrick Johannes Gutenberg University, Mainz. GERMANY
9: 15 Reprogramming using the oocyte
Jose Cibelli LARCel, Seville. SPAIN / Michigan State University. USA
9:35 Vector development for gene therapy in immune related diseases
Francisco Martin GENyO. Granada. SPAIN
9:55 Platforms supporting research: bio-resources
Blanca Miranda Andalusian Biobank . Seville. SPAIN
10:05 Platforms supporting research: genome sequencing
Javier Santoyo-Lopez Andalusian Human Genome Sequencing Centre. Seville. SPAIN
10:15 Debate
10:30 OPENING CEREMONY
11:00 Coffee break
11:30 . CURRENT CLINICAL APPLICATIONS AND FUTURE PERSPECTIVES WITH CELLS,GENES AND TISSUES
Chair: Marta Alarcon Riquelme. GENyO. Granada. SPAIN
11:35 Gene therapies for immunodeficiencies
Adrian Thrasher University College of London. UNITED KINGDOM
11:55 Neuroprotection and Cell Therapy in Parkinson’s Disease
Jose Lopez Barneo IBIS, Seville. SPAIN
12:15 Regenerative Medicine by Somatic Stem Cells: the Paradigm of Epithelial Stem Cells
Michele DeLuca University of Modena and Reggio Emilia. ITALY
12:35 Cell therapy in cardiovascular diseases.
Jose Suarez de Lezo Hospital Reina Sofia. Cordoba. SPAIN
12:55 Mesenchymal Stromal Cells as immune modulators.
Armand Keating Princess Margaret Hospital/ Ontario Cancer Institute. CANADA
13:30 Lunchtime
15:00 ORAL PRESENTATIONS. (5 minutes each one) + (1 minute for questions)
Chair: Antonio Campos. University of Granada. SPAIN
15:00 Cell therapy with autologous bone marrow stem cells in the preoperatory treatment of the remmant liver in patients subsidiary of major hepatectomies. Preliminary results.
Jose Maria Alamo. HU Virgen del Rocio
15:06 Stem cell based therapy: from lab to commercial production.
Matthieu Egloff. Atmi Lifesciences
15:12 Implications of a GMP facility in the work of a hospital, experience of the unit of the University Hospital of Salamanca: teching other specialists what is it about.
Olga Lopez. University Hospital of Salamanca
15:18. Development of zfn- based pre-clinical in vitro cell mode in human embryonic stem cells for wiskott Aldrich syndrome.
Miguel G. Toscano. Pfizer- university of Granada- Junta de Andalucia- Centre for Genomics and Oncological Research (GENYO)
15:24. Efficient sirnatransfection in cell lines and primary neural cells by gold nanoparticle mediated laser transfection.
Dag Heinemann Laser Zentrum Hannovere V. And Research Cluster of Excellence
15:30 Lentiviral gene therapy of rag severe combined immunodeficiency
Niek van Til Erasmus University Medical Center
15:36 Towards gene therapy of x- linked hyper igm syndrome (higm1) with transcriptionally- regulated lentiviral vectors
Pablo Fernandez University of Granada
15:42 Angiogenic performance of magnetized endothelial progrenitor cells for neurorepair therapies
Anna Rosell Vall d’Hebron Research Institute
15:48 Microsphere mediated cellular control- a novel nanotechnology to generate induced pluripotent stem cells
Rosario M. Sanchez- Martin University of Granada
15:54 Characterization and engineering of primary human renal cells for applications in vitro toxicology and kidney tissue engineering
Farah Tasnim Institute of Bioengineering and Nanotechnology
16:00 INDUSTRY PRESENTATIONS. Chair: Rafael Camacho. Fundacion Genoma España
16:00 Osteoarthritis, a big minor disease. Bioiberica, a company specialized on osteoarticular research.
Josep Verges Director PharmaScience. Bioiberica
16:15 Autologous plasma rich in growth factors, a new therapeutic tool
Eduardo Anitua Scientific Director. B.T.I (Biotechnology Institute)
16:30 New Miltenyi Biotec approaches in cell therapy
Jose L. Mateos Clinical Manager. Miltenyi Biotec España
17:00 Coffee break
17:30 REGULATION FOR THE DEVELOPMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS)
Chair: Natividad Cuende. Andalusian Initiative for Advanced Therapies. SPAIN
17:35 Introduction to the regulation of ATMPs
Sol Ruiz. Committee for Advanced Therapies (CAT), EMA /Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). SPAIN
17:55 Common issues in characterizing and manufacturing cell and gene-based therapies
Maria Cristina Galli Committee for Advanced Therapies (CAT), EMA / Istituto Superiore di Sanitá. Roma, ITALY
18:15 Challenges in non-clinical development of cell and gene-based medicinal products
Beatriz Silva Committee for Advanced Therapies (CAT), EMA / INFARMED, Lisboa. PORTUGAL
18:35 Risk-based approach applied to Advanced Therapy Medicinal Products
Paula Salmikangas Committee for Advanced Therapies (CAT), EMA / Finnish Medicines Agency. Helsinki, FINLAND
18:55 How the European countries are regulating the Hospital Exemption for non-industrially manufactured ATMPs?
Ralf Sanzenbacher Paul-Ehrlich-Institut. Langen,GERMANY
19:15 Debate
Friday 29th of June:
08:30 INTELLECTUAL PROPERTY ISSUES AND BUSINESS MODELS AROUND ATMPS
Chair: Javier Montero Plata. Fundación Progreso y Salud. SPAIN
8: 35 Funding and Commercialization Strategies for Advanced Therapies Companies
Gregory Bonfiglio Proteus Venture Partners, Palo Alto, California. USA
8:55 Lessons learnt in the initial development of ATMPs in an academic setting
Martino Introna Laboratorio di Terapia Cellulare e Genica "G. Lanzani".Ospedali Riuniti di Bergamo. ITALY
9:15 Perspectives and future directions for the development of human Embryonic Stem Cell based Therapies.
Jane S. Lebkowski Former Geron Corporation, California. USA
9:35 Patentability of Stem Cells and Allied Technologies: Brüstle case
Gustavo Fuster Hoffmann Eitle. Munich. GERMANY
9:55 21st Century Innovation model for 21st Century Medicines
AjanReginald Cell Therapies Limited. University of Warwick. UNITED KINGDOM
10:15 Debate
10:30 a.m. Coffee break
11:00 EDUCATION AND TRAINING IN CELL AND GENE-BASED THERAPIES
Chair: Indalecio Sanchez Montesinos. University of Granada. SPAIN
11:05 Strategies for teaching long-range inter-disciplinarity: Problems with integrated tissue engineering
Robert Brown University College of London. UNITED KINGDOM
11:35 Teaching cell-based technologies and tissue engineering in Medical Schools
Miguel Alaminos University of Granada. SPAIN
11:45 Team training in Translational Medicine
Jan Nolta Editor of Stem Cells Journal. University of California, Davis, USA
12:05 Beyond research and development, the need for training in manufacturing of ATMPs.
Natividad Cuende Andalusian Initiative for Advanced Therapies. SPAIN
12:25 From education to research: awaking the interest in nanotechnology applications to foster cell and gene therapy developments.
Wolfgang Parak Marbug University. GERMANY
12:45 Debate
13:00 p.m. CLOSING CEREMONY
